Yashma Patel

Assessment of Minimal Residual Disease in Standard-Risk AML

Adam Ivey, Robert K. Hills, Michael A. Simpson et al. · New England Journal of Medicine · 2016 · 836 citations · Full text

Medicine, Hematology, Molecular Genetics +16

Prospective Minimal Residual Disease Monitoring to Predict Relapse of Acute Promyelocytic Leukemia and to Direct Pre-Emptive Arsenic Trioxide Therapy

David Grimwade, Jelena Jovanović, Robert K. Hills et al. · Journal of Clinical Oncology · 2009 · 356 citations · Full text

Medicine, Hematology, Oncology +17

Multiple white matter tract abnormalities underlie cognitive impairment in RRMS

Hui Jing Yu, Christopher Christodoulou, Vikram Bhise et al. · NeuroImage · 2011 · 113 citations

Medicine, Neurology, Neuroscience +14

The impact on outcome of the addition of all-trans retinoic acid to intensive chemotherapy in younger patients with nonacute promyelocytic acute myeloid leukemia: overall results and results in genotypic subgroups defined by mutations in NPM1, FLT3, and CEBPA

Alan K. Burnett, Robert K. Hills, Claire Green et al. · Blood · 2009 · 112 citations · Full text

Medicine, Hematology, Oncology +15

Pediatric multiple sclerosis

Lauren Krupp, Yashma Patel, Vikram Bhise · Annals of Indian Academy of Neurology · 2009 · 25 citations · Full text

Medicine, Neurology, Pediatrics +10